Japanese approval for Mitsubishi Tanabe's teneligliptin

Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508) said Japan's Ministry of Health, Labor and Welfare approved a regulatory application for Tenelia teneligliptin to treat Type II diabetes. Mitsub...